Cyrus Mehta

Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome.

Cavender MA, White WB, Liu Y, Massaro JM, Bergenstal RM, Mehta CR, Zannad F, Heller S, Cushman WC, Cannon CP.

Clin Cardiol. 2018 Aug. 41(8):1022-1027. PMID: 29652078

The distance of the femoral neurovascular bundle from the hip joint: an intraoperative guide to reduce iatrogenic injury.

Mehta CR, Constantinidis A, Farhat M, Suthersan M, Graham E, Kanawati A.

J Orthop Surg Res. 2018 Jun 04. 13(1):135. PMID: 29866137

High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial.

Hwang YC, Morrow DA, Cannon CP, Liu Y, Bergenstal R, Heller S, Mehta C, Cushman W, Bakris GL, Zannad F, White WB.

Diabetes Obes Metab. 2018 03. 20(3):654-659. PMID: 29064626

The potential role and rationale for treatment of heart failure with sodium-glucose co-transporter 2 inhibitors.

Butler J, Hamo CE, Filippatos G, Pocock SJ, Bernstein RA, Brueckmann M, Cheung AK, George JT, Green JB, Januzzi JL, Kaul S, Lam CSP, Lip GYH, Marx N, McCullough PA, Mehta CR, Ponikowski P, Rosenstock J, Sattar N, Salsali A, Scirica BM, Shah SJ, Tsutsui H, Verma S, Wanner C, Woerle HJ, Zannad F, Anker SD.

Eur J Heart Fail. 2017 11. 19(11):1390-1400. PMID: 28836359

Commentary on Freidlin and Korn.

Mehta C.

Clin Trials. 2017 12. 14(6):605-608. PMID: 28776412

A gatekeeping procedure to test a primary and a secondary endpoint in a group sequential design with multiple interim looks.

Tamhane AC, Gou J, Jennison C, Mehta CR, Curto T.

Biometrics. 2018 03. 74(1):40-48. PMID: 28589692

Design and monitoring of multi-arm multi-stage clinical trials.

Ghosh P, Liu L, Senchaudhuri P, Gao P, Mehta C.

Biometrics. 2017 12. 73(4):1289-1299. PMID: 28346823

Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care).

Cavender MA, White WB, Jarolim P, Bakris GL, Cushman WC, Kupfer S, Gao Q, Mehta CR, Zannad F, Cannon CP, Morrow DA.

Circulation. 2017 May 16. 135(20):1911-1921. PMID: 28246236

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.

Heller SR, Bergenstal RM, White WB, Kupfer S, Bakris GL, Cushman WC, Mehta CR, Nissen SE, Wilson CA, Zannad F, Liu Y, Gourlie NM, Cannon CP.

Diabetes Obes Metab. 2017 05. 19(5):664-671. PMID: 28058763

Biomarker-driven population enrichment for adaptive oncology trials with time to event endpoints.

Mehta C, Schäfer H, Daniel H, Irle S.

Stat Med. 2016 12 10. 35(28):5320. PMID: 27813199